The Toronto Stock Exchange reports that it is reviewing the common shares of Antibe Therapeutics Inc. with respect to meeting its continued listing requirements pursuant to the expedited review process. The company has been suspended from trading, effective immediately.
© 2024 Canjex Publishing Ltd. All rights reserved.